My practice is focused on treating high-risk patients with heart attacks, coronary artery disease, valvular heart disease, and aortic disease. My special interests include minimally invasive complex mitral valve repair. We are a Mitral Repair Reference Center, and have a repair success rate of greater than 97%. Additionally, I specialize in minimally invasive heart surgery which helps to improve recovery and allow people to get back to their life and work in a much more comfortable way. I am also trained in the new technique of percutaneous valve replacement for aortic stenosis. Patients are awake during their procedure, and they experience minimal discomfort and leave the hospital in a few days. My current research is focused on the development of devices to enhance the practice of minimally invasive mitral valve repair surgery.

• Selected for inclusion in Guide to America's Top Surgeons (2009) published by the Consumers' Research Council of America

• Gonzalez-Stawinski GV, Cook DJ, Chui J, Gupta S, Navia JL, Hoercher K, Taylor DO, Yamani MH, Starling RC, Smedira NG. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. J Surg Res 2007;142:233-8.
• Gupta S, Cook DJ, Sharma M, Stawinski G, Taylor D, Yamani MH, Young JB, Coleman L, Hartman D, Campbell J, Ludrosky K, Starling R, Smedira N. “Virtual crossmatching” allows the expansion of effective donor pool for HLA-sensitized patients. J Heart Lung Transplant 2006; 25 (2 Suppl):140.
• Gupta S, Steiger E, Sands M. Vascular access for the patient receiving parenteral nutrition. In: Buchman A, editor. Clinical Nutrition and Gastrointestinal Disease. Thorofare, NJ: Slack, 2006: 409-16.
• Hartley JE, Church JM, Gupta S, McGannon E, Fazio VW. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 2004;47:334-40.
• Sharma M, Gupta S, Cook DJ, Gonzales-Stawinski G, Murthy S, Mason D, Mehta A, Pettersson G. Pre-transplant anti-HLA antibodies are associated with decreased survival in lung transplantation: a single center experience. Transplantation 2006;82(1 Suppl 2):276-7.
• Yamani MH, Cook DJ, Rodriguez ER, Thomas DM, Gupta S, Alster J, Taylor DO, Hobbs R, Young JB, Smedira N, Starling RC. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. J Heart Lung Transplant 2006;25:1283-9.